Acrylamide
This article was originally published in The Rose Sheet
Executive Summary
Center for the Evaluation of Risks to Human Reproduction concludes there is "negligible concern" for adverse reproductive and developmental effects from exposure to acrylamide in the general population and there is "minimal concern" for acrylamide-induced heritable effects. There is "some concern" for adverse reproductive and developmental effects from occupational exposure to the chemical, the panel says. CERHR assessed the safety of acrylamide, an ingredient used in some cosmetics, during a meeting in May (1"The Rose Sheet" May 17, 2004, p. 9). The expert panel report from this evaluation will be available in about four weeks...
You may also be interested in...
CERHR Expert Panel To Review Acrylamide Safety
Human exposure to acrylamide through dermal contact with cosmetics and other consumer products is possible because the polyacrylamide used in these products may contain free acrylamide, the National Toxicology Program Center for the Evaluation of Risks to Human Reproduction states in a 1draft report on the chemical
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.